# BENDITA BEnznidazole New Doses Improved Treatment and Associations

> **NCT03378661** · PHASE2 · UNKNOWN · sponsor: **Drugs for Neglected Diseases** · enrollment: 210 (actual)

## Conditions studied

- Chagas Disease

## Interventions

- **DRUG:** Benznidazole
- **DRUG:** E1224
- **DRUG:** E1224 Placebo
- **DRUG:** Benznidazole Placebo

## Key facts

- **NCT ID:** NCT03378661
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-30
- **Primary completion:** 2018-01-28
- **Final completion:** 2018-07-27
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378661, "BENDITA BEnznidazole New Doses Improved Treatment and Associations". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03378661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*